Cerberus considers Covis Pharma sale: Bloomberg

Cerberus Capital Management is weighing a sale of Covis Pharma Holdings Sarl, which could fetch about $800 million, Bloomberg reported. Covis, a specialty pharmaceutical company, has attracted attention from private equity, the story said.